BFM
HSTO

Boothbay Fund Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Boothbay Fund Management’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-234
Closed -$50K – 954
2019
Q1 		$50K Sell
234
-712
-75% -$287K ﹤0.01% 701
2018
Q4 		$327K Buy
+946
New +$735K 0.05% 364

Other funds holding HSTO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $58.9B AUM 51.73% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Boothbay Fund Management's HSTO Position: Q2 2019 in Review

Boothbay Fund Management sold out of Histogen Inc. Common Stock (HSTO) in Q2 2019, closing a stake of 234 shares — an estimated $50K sold.

Boothbay Fund Management first reported a position in HSTO in Q4 2018 and held it in 2 quarters. The position peaked at $327K in Q4 2018. 36 funds tracked by Wall St. Rank hold HSTO as of Q2 2019.

  • Boothbay Fund Management reported no remaining Histogen Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Boothbay Fund Management sold 234 Histogen Inc. Common Stock shares in Q2 2019, an estimated $50K.
  • Boothbay Fund Management first reported a position in Histogen Inc. Common Stock in Q4 2018 and held it in 2 quarters.
  • Boothbay Fund Management's Histogen Inc. Common Stock position peaked at $327K in Q4 2018.
  • 36 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2019.

Based on Boothbay Fund Management's 13F filing for Q2 2019, filed 14 Aug 2019.